Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.06
WOOF's Cash to Debt is ranked lower than
82% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. WOOF: 0.06 )
Ranked among companies with meaningful Cash to Debt only.
WOOF' s Cash to Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.13 Max: No Debt
Current: 0.06
Equity to Asset 0.45
WOOF's Equity to Asset is ranked lower than
54% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. WOOF: 0.45 )
Ranked among companies with meaningful Equity to Asset only.
WOOF' s Equity to Asset Range Over the Past 10 Years
Min: 0.1  Med: 0.49 Max: 0.65
Current: 0.45
0.1
0.65
Interest Coverage 12.38
WOOF's Interest Coverage is ranked higher than
59% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 7.64 vs. WOOF: 12.38 )
Ranked among companies with meaningful Interest Coverage only.
WOOF' s Interest Coverage Range Over the Past 10 Years
Min: 5.46  Med: 10.97 Max: 15.55
Current: 12.38
5.46
15.55
F-Score: 6
Z-Score: 3.70
M-Score: -2.62
WACC vs ROIC
8.98%
9.94%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 15.60
WOOF's Operating margin (%) is ranked higher than
78% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 7.23 vs. WOOF: 15.60 )
Ranked among companies with meaningful Operating margin (%) only.
WOOF' s Operating margin (%) Range Over the Past 10 Years
Min: 5.47  Med: 15.23 Max: 20.17
Current: 15.6
5.47
20.17
Net-margin (%) 9.64
WOOF's Net-margin (%) is ranked higher than
70% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 4.83 vs. WOOF: 9.64 )
Ranked among companies with meaningful Net-margin (%) only.
WOOF' s Net-margin (%) Range Over the Past 10 Years
Min: 2.68  Med: 8.94 Max: 10.73
Current: 9.64
2.68
10.73
ROE (%) 17.72
WOOF's ROE (%) is ranked higher than
76% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 9.80 vs. WOOF: 17.72 )
Ranked among companies with meaningful ROE (%) only.
WOOF' s ROE (%) Range Over the Past 10 Years
Min: 3.98  Med: 14.17 Max: 28.56
Current: 17.72
3.98
28.56
ROA (%) 8.30
WOOF's ROA (%) is ranked higher than
74% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 4.14 vs. WOOF: 8.30 )
Ranked among companies with meaningful ROA (%) only.
WOOF' s ROA (%) Range Over the Past 10 Years
Min: 2.23  Med: 7.52 Max: 11.28
Current: 8.3
2.23
11.28
ROC (Joel Greenblatt) (%) 77.83
WOOF's ROC (Joel Greenblatt) (%) is ranked higher than
83% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 19.67 vs. WOOF: 77.83 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
WOOF' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 23.39  Med: 68.4 Max: 116.35
Current: 77.83
23.39
116.35
Revenue Growth (3Y)(%) 10.50
WOOF's Revenue Growth (3Y)(%) is ranked higher than
60% of the 180 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. WOOF: 10.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
WOOF' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 8.7 Max: 134.1
Current: 10.5
0
134.1
EBITDA Growth (3Y)(%) 40.60
WOOF's EBITDA Growth (3Y)(%) is ranked higher than
93% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. WOOF: 40.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
WOOF' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 9.1 Max: 225.3
Current: 40.6
0
225.3
EPS Growth (3Y)(%) 71.20
WOOF's EPS Growth (3Y)(%) is ranked higher than
94% of the 132 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. WOOF: 71.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
WOOF' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 7.3 Max: 100
Current: 71.2
0
100
GuruFocus has detected 3 Warning Signs with VCA Inc $WOOF.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» WOOF's 10-Y Financials

Financials (Next Earnings Date: 2017-02-09)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

WOOF Guru Trades in Q1 2016

Paul Tudor Jones 8,200 sh (New)
Pioneer Investments 106,433 sh (+30.13%)
Third Avenue Management 132,590 sh (unchged)
Steven Cohen Sold Out
Larry Robbins 4,876,303 sh (-22.85%)
Jim Simons 960,800 sh (-23.25%)
Joel Greenblatt 4,580 sh (-77.29%)
» More
Q2 2016

WOOF Guru Trades in Q2 2016

Columbia Wanger 200,784 sh (New)
Steven Cohen 13,400 sh (New)
Pioneer Investments 106,433 sh (unchged)
Joel Greenblatt Sold Out
Paul Tudor Jones Sold Out
Jim Simons 853,400 sh (-11.18%)
Third Avenue Management 93,539 sh (-29.45%)
Larry Robbins 1,421,323 sh (-70.85%)
» More
Q3 2016

WOOF Guru Trades in Q3 2016

Ken Fisher 2,921 sh (New)
Paul Tudor Jones 3,900 sh (New)
Steven Cohen 78,700 sh (+487.31%)
Pioneer Investments 111,151 sh (+4.43%)
Larry Robbins Sold Out
Columbia Wanger 195,940 sh (-2.41%)
Third Avenue Management 80,794 sh (-13.63%)
Jim Simons 615,000 sh (-27.94%)
» More
Q4 2016

WOOF Guru Trades in Q4 2016

Ken Fisher 2,921 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with WOOF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 541940    SIC: 742
Compare:OTCPK:CAKFY, OTCPK:SKHCF, NYSE:MD, NYSE:HLS, OTCPK:NMHLY, NAS:ACHC, NYSE:EVHC, NYSE:CHE, OTCPK:LTGHY, NAS:LPNT, NAS:SCAI, OTCPK:BDULF, NYSE:SEM, NYSE:AMN, NYSE:THC, NAS:AMED, NAS:PAHC, NAS:TVTY, NYSE:USPH, NAS:SGRY » details
Traded in other countries:VCA.Germany,
VCA Inc provides veterinary services and diagnostic testing to support veterinary care and sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market.

VCA Inc, formerly known as VCA Antech Inc was formed in 1986 as a Delaware corporation and during the 1990s established a position in the animal hospital and veterinary diagnostic laboratory markets through both internal growth and acquisitions. It is a national animal healthcare company operating in the United States and Canada. It provides veterinary services and diagnostic testing to support veterinary care and sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company operates in four segments: animal hospitals, veterinary diagnostic laboratories, veterinary medical technology and Vetstreet. The Companys animal hospitals offer a full range of general medical and surgical services for companion animals. Its animal hospitals treat diseases and injuries, provide pharmaceutical products and perform a variety of pet-wellness programs, including health examinations, diagnostic testing, vaccinations, spaying, neutering and dental care. At December 31, 2013, it operated 609 animal hospitals throughout 41 states and 4 Canadian provinces. The Company operates a full-service veterinary diagnostic laboratory network serving all 50 states and certain areas in Canada. Its laboratory network provides sophisticated testing and consulting services used by veterinarians in the detection, diagnosis, evaluation, monitoring, treatment and prevention of diseases and other conditions affecting animals. At December 31, 2013, it operated 56 laboratories of various sizes located strategically throughout the United States and Canada. The Companys Medical Technology business sells digital radiography and ultrasound imaging equipment, provides education and training on the use of that equipment, provides consulting and mobile imaging services, and sells software and ancillary services to the veterinary market. The Company's sales agents market and sell its products and services to veterinary hospitals and universities. It mainly directs its marketing efforts toward its existing clients through customer education efforts. It license its proprietary software, TruDR. TruDR allows for the capture of digital x-ray images and transmits those images to a computer containing archiving and reviewing software. It also provide mobile imaging, consulting, education and training services to its customers. The companion animal healthcare industry is competitive and subject to continual change in the manner in which services are delivered and providers are selected. Certain states have laws that prohibit business corporations from providing, or holding themselves out as providers of, veterinary medical care.

Ratios

vs
industry
vs
history
P/E(ttm) 31.98
WOOF's P/E(ttm) is ranked lower than
62% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 26.17 vs. WOOF: 31.98 )
Ranked among companies with meaningful P/E(ttm) only.
WOOF' s P/E(ttm) Range Over the Past 10 Years
Min: 10.31  Med: 21.66 Max: 56.8
Current: 31.98
10.31
56.8
Forward P/E 27.93
WOOF's Forward P/E is ranked lower than
83% of the 66 Companies
in the Global Medical Care industry.

( Industry Median: 18.90 vs. WOOF: 27.93 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 31.98
WOOF's PE(NRI) is ranked lower than
61% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 26.51 vs. WOOF: 31.98 )
Ranked among companies with meaningful PE(NRI) only.
WOOF' s PE(NRI) Range Over the Past 10 Years
Min: 10.31  Med: 21.66 Max: 56.8
Current: 31.98
10.31
56.8
Price/Owner Earnings (ttm) 30.39
WOOF's Price/Owner Earnings (ttm) is ranked lower than
59% of the 91 Companies
in the Global Medical Care industry.

( Industry Median: 26.85 vs. WOOF: 30.39 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
WOOF' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 9.71  Med: 21.01 Max: 67.8
Current: 30.39
9.71
67.8
P/B 5.14
WOOF's P/B is ranked lower than
80% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 2.50 vs. WOOF: 5.14 )
Ranked among companies with meaningful P/B only.
WOOF' s P/B Range Over the Past 10 Years
Min: 1.23  Med: 2.66 Max: 7.79
Current: 5.14
1.23
7.79
P/S 3.09
WOOF's P/S is ranked lower than
75% of the 237 Companies
in the Global Medical Care industry.

( Industry Median: 1.45 vs. WOOF: 3.09 )
Ranked among companies with meaningful P/S only.
WOOF' s P/S Range Over the Past 10 Years
Min: 0.94  Med: 1.74 Max: 3.42
Current: 3.09
0.94
3.42
PFCF 31.33
WOOF's PFCF is ranked lower than
65% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 23.25 vs. WOOF: 31.33 )
Ranked among companies with meaningful PFCF only.
WOOF' s PFCF Range Over the Past 10 Years
Min: 10.45  Med: 18.47 Max: 37.05
Current: 31.33
10.45
37.05
POCF 20.53
WOOF's POCF is ranked lower than
73% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 14.44 vs. WOOF: 20.53 )
Ranked among companies with meaningful POCF only.
WOOF' s POCF Range Over the Past 10 Years
Min: 7.26  Med: 12.63 Max: 26.65
Current: 20.53
7.26
26.65
EV-to-EBIT 16.37
WOOF's EV-to-EBIT is ranked higher than
64% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 20.40 vs. WOOF: 16.37 )
Ranked among companies with meaningful EV-to-EBIT only.
WOOF' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.3  Med: 13.9 Max: 29.5
Current: 16.37
7.3
29.5
EV-to-EBITDA 13.40
WOOF's EV-to-EBITDA is ranked higher than
56% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 14.49 vs. WOOF: 13.40 )
Ranked among companies with meaningful EV-to-EBITDA only.
WOOF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.5  Med: 11.45 Max: 18
Current: 13.4
6.5
18
PEG 2.29
WOOF's PEG is ranked higher than
60% of the 82 Companies
in the Global Medical Care industry.

( Industry Median: 2.76 vs. WOOF: 2.29 )
Ranked among companies with meaningful PEG only.
WOOF' s PEG Range Over the Past 10 Years
Min: 0.42  Med: 1.36 Max: 73.79
Current: 2.29
0.42
73.79
Shiller P/E 55.90
WOOF's Shiller P/E is ranked lower than
78% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 28.63 vs. WOOF: 55.90 )
Ranked among companies with meaningful Shiller P/E only.
WOOF' s Shiller P/E Range Over the Past 10 Years
Min: 14.95  Med: 29.08 Max: 75.98
Current: 55.9
14.95
75.98
Current Ratio 1.00
WOOF's Current Ratio is ranked lower than
64% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 1.27 vs. WOOF: 1.00 )
Ranked among companies with meaningful Current Ratio only.
WOOF' s Current Ratio Range Over the Past 10 Years
Min: 0.53  Med: 1.53 Max: 5.59
Current: 1
0.53
5.59
Quick Ratio 0.75
WOOF's Quick Ratio is ranked lower than
76% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 1.14 vs. WOOF: 0.75 )
Ranked among companies with meaningful Quick Ratio only.
WOOF' s Quick Ratio Range Over the Past 10 Years
Min: 0.47  Med: 1.33 Max: 5.41
Current: 0.75
0.47
5.41
Days Inventory 11.18
WOOF's Days Inventory is ranked higher than
64% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 17.58 vs. WOOF: 11.18 )
Ranked among companies with meaningful Days Inventory only.
WOOF' s Days Inventory Range Over the Past 10 Years
Min: 10.06  Med: 12.37 Max: 14.23
Current: 11.18
10.06
14.23
Days Sales Outstanding 12.46
WOOF's Days Sales Outstanding is ranked higher than
88% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 42.10 vs. WOOF: 12.46 )
Ranked among companies with meaningful Days Sales Outstanding only.
WOOF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 11.51  Med: 13.06 Max: 16.51
Current: 12.46
11.51
16.51
Days Payable 10.79
WOOF's Days Payable is ranked lower than
86% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 38.65 vs. WOOF: 10.79 )
Ranked among companies with meaningful Days Payable only.
WOOF' s Days Payable Range Over the Past 10 Years
Min: 9.68  Med: 11.29 Max: 12.28
Current: 10.79
9.68
12.28

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 3.00
WOOF's 3-Year Average Share Buyback Ratio is ranked higher than
94% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. WOOF: 3.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
WOOF' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -4  Med: -0.7 Max: 0
Current: 3
-4
0

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 2.22
WOOF's Price/Projected FCF is ranked lower than
68% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.72 vs. WOOF: 2.22 )
Ranked among companies with meaningful Price/Projected FCF only.
WOOF' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.63  Med: 1.6 Max: 113.29
Current: 2.22
0.63
113.29
Price/DCF (Earnings Based) 2.99
WOOF's Price/DCF (Earnings Based) is ranked lower than
90% of the 29 Companies
in the Global Medical Care industry.

( Industry Median: 1.65 vs. WOOF: 2.99 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.77
WOOF's Price/Median PS Value is ranked lower than
86% of the 207 Companies
in the Global Medical Care industry.

( Industry Median: 1.02 vs. WOOF: 1.77 )
Ranked among companies with meaningful Price/Median PS Value only.
WOOF' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.55  Med: 1.11 Max: 2.74
Current: 1.77
0.55
2.74
Price/Peter Lynch Fair Value 1.60
WOOF's Price/Peter Lynch Fair Value is ranked higher than
65% of the 46 Companies
in the Global Medical Care industry.

( Industry Median: 2.34 vs. WOOF: 1.60 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
WOOF' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.66  Med: 1.25 Max: 6.11
Current: 1.6
0.66
6.11
Earnings Yield (Greenblatt) (%) 6.12
WOOF's Earnings Yield (Greenblatt) (%) is ranked higher than
71% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 3.80 vs. WOOF: 6.12 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
WOOF' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 3.4  Med: 7.2 Max: 13.8
Current: 6.12
3.4
13.8
Forward Rate of Return (Yacktman) (%) 22.42
WOOF's Forward Rate of Return (Yacktman) (%) is ranked higher than
80% of the 114 Companies
in the Global Medical Care industry.

( Industry Median: 9.76 vs. WOOF: 22.42 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
WOOF' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -3.4  Med: 17.3 Max: 73.1
Current: 22.42
-3.4
73.1

More Statistics

Revenue (TTM) (Mil) $2,408
EPS (TTM) $ 2.84
Beta1.03
Short Percentage of Float1.73%
52-Week Range $44.00 - 91.58
Shares Outstanding (Mil)81.57

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 2,522 2,746 3,109
EPS ($) 2.91 3.21 3.65
EPS w/o NRI ($) 2.91 3.21 3.65
EPS Growth Rate
(3Y to 5Y Estimate)
9.88%
Dividends Per Share ($)
» More Articles for WOOF

Headlines

Articles On GuruFocus.com
Health Care Companies Showing Good Defensive Potential Dec 22 2016 
WOOF: Health Care Without the Drama Dec 12 2016 
2 Picks in Growing Pet Industry Jan 30 2016 
GuruFocus Real Time Picks of the Week Jun 06 2014 
Morning Coffee: Real-Time Picks May 30 2014 
Building a Technical Swing-Trade with VCA Antech (WOOF) Oct 17 2013 
Arnold Van Den Berg Trims Staples, Sells Out of Dell and Others - Q4 Updates Jan 09 2013 
Weekly Guru Bargains Highlights: WOOF, VPRT, IBN, PHG, CTRP Oct 15 2011 
Arnold Van Den Berg's Top 5 Third-Quarter Buys Oct 11 2011 
Earning Power: Return on Something Sep 23 2011 

More From Other Websites
WeissLaw LLP: VCA, Inc. Acquisition May Not Be in the Best Interests of WOOF Shareholders Jan 18 2017
Amazon, Merck, Freshpet: Jim Cramer's Views Jan 16 2017
VCA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of VCA Inc. (WOOF) Over the... Jan 13 2017
U.S. Pet Care Spending Has Grown 60% Since 2006 (WOOF, IDXX) Jan 13 2017
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of... Jan 12 2017
VCA Looks to Gain Scale and Size by Being Part of Mars Jan 12 2017
VCA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates... Jan 11 2017
VCA downgraded by Credit Suisse Jan 11 2017
Robbins Arroyo LLP: Acquisition of VCA Inc. (WOOF) by Mars, Incorporated (Private) May Not Be in... Jan 10 2017
VCA, Inc.: Strong price momentum but will it sustain? Jan 10 2017
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of VCA Inc.... Jan 10 2017
VCA Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Merger with Mars,... Jan 10 2017
Jim Cramer's Top Takeaways: VCA, Johnson Controls, Adient Jan 10 2017
The Merger Frenzy Is On: Here's What to Expect from the Rest of 2017 Jan 09 2017
The Real Apple of the Dow's Eye -- ICYMI Jan 09 2017
VCA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 09 2017
Business Highlights Jan 09 2017
Business Highlights Jan 09 2017
Harwood Feffer LLP Announces Investigation of VCA Inc. Jan 09 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)